New rotor device aims to speed up pancreatitis recovery
NCT ID NCT07253350
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new device called Endorotor to standard methods for removing dead pancreatic tissue in patients with severe pancreatitis. About 64 adults who need this procedure will be randomly assigned to one of two groups. The goal is to see if the Endorotor clears the tissue faster and with fewer complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Endorotor PED® system (a medical device for removing dead tissue)
What this could lead to
If it works, this could speed up recovery from severe pancreatitis and reduce complications, offering a more effective way to clear dead tissue.
What could go wrong
This is a small early-stage trial (64 people), so results may not apply to everyone. The device may not work better than standard techniques and carries risks like bleeding or infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE NECROTIZING PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Beaujon, APHP
RECRUITINGClichy, France
Contact Phone: •••-•••-•••• Email: •••••@•••••